Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. News & events
Filter by
  • Filter by
  • Remove this filter Infectious disease: Invasive pneumococcal disease
  • Infectious disease
    • Invasive pneumococcal disease (12)
    • Vaccine preventable diseases (12)
    • Pneumococcal disease (12)
    • Streptococcus pneumoniae (12)
    • S. pneumoniae (12)
    • Respiratory diseases (2)
    • Influenza (2)
    • Influenza in humans, seasonal (1)
    • Seasonal influenza (1)
    • Flu (1)
  • Public health area
    • Immunisation (9)
    • Vaccination (9)
    • Active immunisation (9)
    • Surveillance (4)
    • Prevention and control (1)
    • Public health response (1)
    • Public health threat (1)
    • Vaccine safety (1)
    • Antimicrobial consumption (1)
    • Antimicrobial resistance (1)
    • Disease prevention (1)
    • Prophylaxis (1)
    • Control campaign (1)
    • Outbreak (1)
    • Antibiotic resistance (1)
    • Threats and outbreaks (1)
  • Country
    • Europe (5)
  • Type
    • News (13)
    • ECDC comment (12)
  • All (13)
  • News (13)
  • Page 1 of 2 // 12 Results found
    • Sort by:

News

Pneumococcal meningitis in French children before and after the introduction of pneumococcal conjugate vaccineArchived

ECDC comment - 11 Feb 2011

In the context of an active nationwide surveillance network, this study describes pneumoccocal meningitis in children aged from 1 day to 15 years during a 8 year study period (2001-2008) in France. 951 pneumoccocal meningitis cases were reported among 3312 children with bacterial meningitis. T

  • Immunisation
  • Pneumococcal disease

News

The current status of invasive pneumococcal disease in PolandArchived

ECDC comment - 11 Mar 2011

This study assesses the incidence of IPD (2006–2009), the serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates.

  • Immunisation
  • Pneumococcal disease
  • Poland
  • Surveillance

News

Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challengesArchived

ECDC comment - 8 Apr 2011

In Belgium, the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into the national schedule in 2007.

  • Immunisation
  • Pneumococcal disease

News

Serotype replacement in disease after pneumococcal vaccinationArchived

ECDC comment - 20 Apr 2011

The heptavalent pneumococcal conjugate vaccine (PCV7) targets seven of the more than 92 pneumococcal serotypes. Concerns have been raised that non-vaccine serotypes (NVTs) could increase in prevalence and reduce the benefits of vaccination. Indeed, among asymptomatic carriers, the prevalence of NVTs has increased substantially, and consequently, there has been little or no net change in the bacterial carriage prevalence.

  • Immunisation
  • Pneumococcal disease
  • Surveillance

News

Are statins protective in patients with severe respiratory infections? Two new studies from EuropeArchived

ECDC comment - 6 May 2011

In recent years there have been a series of arguments and findings suggesting that Statins (HMG-CoA reductase inhibitors) which used widely to lower cholesterol levels may also be important in reducing the risk associated with severe infective conditions.

  • Europe
  • Influenza
  • Influenza in humans, seasonal
  • Pneumococcal disease
  • Public health response

News

Paediatric pneumococcal disease in Central EuropeArchived

ECDC comment - 7 Jul 2011

The authors present an appraisal of the pneumococcal epidemiological situation in 11 Central European countries. Data are based on study findings presented at the 12th Central European Vaccine Advisory Group (CEVAG) meeting, held on 21–22 May 2010 in Sofia, Bulgaria, and a literature review of the PubMed database.

  • Europe
  • Pneumococcal disease
  • Public health threat
  • Surveillance

News

Serotype replacement in disease after pneumococcal vaccinationArchived

ECDC comment - 9 Dec 2011

The evidence presented in the article strongly supports the notion that serotype replacement has occurred in invasive pneumococcal disease in most populations and is caused by the vaccine.

  • Immunisation
  • Pneumococcal disease

News

Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate VaccineArchived

ECDC comment - 16 Dec 2011

This study demonstrates that PCV13 is immunogenic and safe in children previously vaccinated with PCV7. By eliciting high antibacterial immune responses to the additional serotypes, PCV13 provides protection against these serotypes, which are important causes of pneumococcal disease globally.

  • Immunisation
  • Pneumococcal disease
  • Vaccine safety

News

Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in FranceArchived

ECDC comment - 28 Mar 2012

This study found a marked reduction in vaccine serotype carriage after PCV7 implementation. The overall pneumococcal, H. influenzae and S. aureus carriage decreased slightly, but not significantly.

  • Pneumococcal disease

News

Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in childrenArchived

ECDC comment - 16 Aug 2012

The study compares the incidence and serotype distribution of invasive pneumococcal disease (IPD) for pneumococcal meningitis and non-meningitis IPD in children from 2007 to 2010 with reference to the pre-vaccination period from 1997 to 2001 in Germany.

  • Germany
  • Immunisation
  • Pneumococcal disease
  • Surveillance

Pagination

  • Current page 1
  • Page 2
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us